Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease

Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A. +6 more·1998·Journal of Neural Transmission

Cited by (746)

Items 201–300 of 746

  1. Review: Relationship of type 2 diabetes to human brain pathology
    J. J. Pruzin, Peter T. Nelson, Erin L. Abner, Zoe Arvanitakis · 2018 · Neuropathology and Applied Neurobiology
  2. The effect of intrahippocampal insulin microinjection on spatial learning and memory
    Maryam Moosavi, Nasser Naghdi, Nader Maghsoudi, Saleh Zahediasl · 2006 · Hormones and Behavior
  3. Metabolic Plasticity of Astrocytes and Aging of the Brain
    Mitsuhiro Morita, Hiroko Ikeshima‐Kataoka, Marko Kreft, Nina Vardjan, Robert Zorec, Mami Noda · 2019 · International Journal of Molecular Sciences
  4. An Integrated and Unifying Hypothesis for the Metabolic Basis of Sporadic Alzheimer's Disease
    Adnan Erol · 2008 · Journal of Alzheimer s Disease
  5. Amyloid-beta impairs insulin signaling by accelerating autophagy-lysosomal degradation of LRP-1 and IR-β in blood-brain barrier endothelial cells in vitro and in 3XTg-AD mice
    Chaitanya Chakravarthi Gali, Elham Fanaee‐Danesh, Martina Zandl‐Lang, Nicole Maria Albrecher, Carmen Tam‐Amersdorfer, Anika Stracke, Vinay Sachdev, Florian Reichmann, Yidan Sun, Afrim Avdili et al. · 2019 · Molecular and Cellular Neuroscience
  6. A metabolic and functional overview of brain aging linked to neurological disorders
    Najma Zaheer Baquer, Asia Taha, Pardeep Kumar, Patricia McLean, Sudha Mahajan Cowsik, R.K. Kale, R. Singh, Deepak Sharma · 2009 · Biogerontology
  7. Therapeutic applications of iminosugars: Current perspectives and future opportunities
    Horne, Graeme, Wilson, Francis X. · 2011 · Progress in medicinal chemistry
  8. Intranasal Insulin Improves Age-Related Cognitive Deficits and Reverses Electrophysiological Correlates of Brain Aging
    Shaniya Maimaiti, Katie L. Anderson, Chris DeMoll, Lawrence D. Brewer, Benjamin A. Rauh, John C. Gant, Eric M. Blalock, Nada M. Porter, Olivier Thibault · 2015 · The Journals of Gerontology Series A
  9. Intersection between metabolic dysfunction, high fat diet consumption, and brain aging
    Romina María Uranga, Annadora J. Bruce‐Keller, Christopher D. Morrison, Sun Ok Fernandez‐Kim, Philip J. Ebenezer, Le Zhang, Kalavathi Dasuri, Jeffrey N. Keller · 2010 · Journal of Neurochemistry
  10. Inhibition of the Neuronal Insulin Receptor An in Vivo Model for Sporadic Alzheimer Disease?
    Siegfried Hoyer, Sae Kyung Lee, Thomas Löffler, Reinhard Schliebs · 2000 · Annals of the New York Academy of Sciences
  11. Inhibition of the Neuronal Insulin Receptor Causes Alzheimer‐like Disturbances in Oxidative/Energy Brain Metabolism and in Behavior in Adult Rats
    Siegfried Hoyer, Heinrich Lannert · 1999 · Annals of the New York Academy of Sciences
  12. Diabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences
    Domenico Sergi, Justine Renaud, Nicola Simola, Maria‐Grazia Martinoli · 2019 · Frontiers in Aging Neuroscience
  13. Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains
    Linda Adzovic, Ashley E Lynn, Heather M. D’Angelo, Alexis Mary Crockett, Roxanne M. Kaercher, Sarah E Royer, Sarah C. Hopp, Gary L. Wenk · 2015 · Journal of Neuroinflammation
  14. Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways
    Marzia Perluigi A, Eugenio Barone, Fabio Di Domenico, David Allan Butterfield · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  15. Permeability of the Blood-Brain Barrier to Albumin and Insulin in the Young and Aged SAMP8 Mouse
    William A. Banks, Susan A. Farr, John Edward Morley · 2000 · The Journals of Gerontology Series A
  16. Iron Deposition Leads to Hyperphosphorylation of Tau and Disruption of Insulin Signaling
    Wan, Wenbin, Cao, Lan, Kalionis, Bill, Murthi, Padma, Xia, Shijin, Guan, Yangtai · 2019 · Frontiers in Neurology
  17. Insulin signalling in Alzheimer′s disease and diabetes: from epidemiology to molecular links
    Elena M. Ribé, Simon Lovestone · 2016 · Journal of Internal Medicine
  18. The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease
    Shengnan Shen, Qiwen Liao, Yin Kwan Wong, Xiao Chen, Chuanbin Yang, Chengchao Xu, Jichao Sun, Jigang Wang · 2022 · International Journal of Biological Sciences
  19. The paradox of neuronal insulin action and resistance in the development of aging‐associated diseases
    Sophie Marie Steculorum, Maite Solas, Jens C. Brüning · 2014 · Alzheimer s & Dementia
  20. Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons – implications for Alzheimer's disease
    Wolfgang Härtig, Jens Stieler, Ate S. Boerema, Jennifer Wolf, Udo Schmidt, Jana Weißfuß, Torsten Bullmann, Arjen M. Strijkstra, Thomas Arendt · 2007 · European Journal of Neuroscience
  21. Alzheimer's Disease and Diabetes: An Integrative View of the Role of Mitochondria, Oxidative Stress, and Insulin
    Paula Isabel Moreira · 2012 · Journal of Alzheimer s Disease
  22. Loss of Neuroprotective Survival Signal in Mice Lacking Insulin Receptor Gene in Rod Photoreceptor Cells
    Ammaji Rajala, Masaki Tanito, Yun Z. Le, C. Ronald Kahn, Raju V. S. Rajala · 2008 · Journal of Biological Chemistry
  23. Amyloid-β Induces Hepatic Insulin Resistance In Vivo via JAK2
    Yi Zhang, Ben Zhi Zhou, Bo Deng, Fang Zhang, Jingxia Wu, Yuangao Wang, Yingying Le, Qiwei Zhai · 2012 · Diabetes
  24. Insulin inhibits amyloid β-induced cell death in cultured human brain pericytes
    Annemieke A.M. Rensink, Irene Otte‐Höller, Roelie de Boer, Remko R. Bosch, Hans J. ten Donkelaar, Robert M.W. de Waal, Marcel M. Verbeek, Berry P. H. Kremer · 2003 · Neurobiology of Aging
  25. Impaired peripheral glucose homeostasis and Alzheimer's disease
    Nadeeja Wijesekara, Rafaella Araujo Gonçalves, Fernanda G. De Felice, Paul E. Fraser · 2017 · Neuropharmacology
  26. Immune system and glucose metabolism interaction in schizophrenia: A chicken–egg dilemma
    Johann Steiner, Hans‐Gert Bernstein, Kolja Schiltz, Ulf Müller, Sabine Westphal, Hemmo A. Drexhage, Bernhard Bogerts · 2012 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  27. Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOE ɛ4 Carriers
    Erika Jane Starks, J. Patrick O’Grady, Siobhan M. Hoscheidt, Annie Marie Racine, Cynthia M. Carlsson, Henrik Zetterberg, Kaj Blennow, Ozioma C. Okonkwo, Luigi Puglielli, Sanjay Asthana et al. · 2015 · Journal of Alzheimer s Disease
  28. Insulin resistance in the brain: An old-age or new-age problem?
    Ritchie Williamson, Alison D. McNeilly, Calum D. Sutherland · 2012 · Biochemical Pharmacology
  29. Insulin receptor and ageing
    Tamàs Fülöp, Anis Larbi, Nadine Douziech · 2003 · Pathologie Biologie
  30. The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer’s disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer’s disease?
    Schnurra, I., Bernstein, H.-G., Riederer, P., Braunewell, K.-H. · 2001 · Neurobiology of Disease
  31. Neural ageing and synaptic plasticity: prioritizing brain health in healthy longevity
    Navakkode, Sheeja, Kennedy, Brian K. · 2024 · Frontiers in Aging Neuroscience
  32. Insulin Resistance in Peripheral Tissues and the Brain: A Tale of Two Sites
    Rhea, Elizabeth M., Banks, William A., Raber, Jacob · 2022 · Biomedicines
  33. O-GlcNAcylation as a Therapeutic Target for Alzheimer’s Disease
    Jinsu Park, Mitchell K.P. Lai, Thiruma Valavan Arumugam, Dong‐Gyu Jo · 2020 · NeuroMolecular Medicine
  34. The emerging link between O-GlcNAcylation and neurological disorders
    Xiaofeng Ma, He Li, Yating He, Junwei Hao · 2017 · Cellular and Molecular Life Sciences
  35. Role of Insulin in Neurotrauma and Neurodegeneration: A Review
    Michael Shaughness, Deanna Acs, Fiona Brabazon, Nicole Hockenbury, Kimberly R. Byrnes · 2020 · Frontiers in Neuroscience
  36. Insulin protects against stress-induced impairments in water maze performance
    Maryam Moosavi, Nasser Naghdi, Nader Maghsoudi, S Zahediasl · 2006 · Behavioural Brain Research
  37. Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
    Tramutola, Antonella, Lanzillotta, Chiara, Di Domenico, Fabio, Head, Elizabeth, Butterfield, D. Allan, Perluigi, Marzia, Barone, Eugenio · 2020 · Neurobiology of Disease
  38. Type 2 Diabetes and Parkinson's Disease: A Focused Review of Current Concepts
    Patrick W. Cullinane, Eduardo De Pablo‐Fernández, Annekatrin König, Tiago F. Outeiro, Zane Jaunmuktane, Thomas T. Warner · 2022 · Movement Disorders
  39. Improved cognitive-cerebral function in older adults with chromium supplementation
    Robert Krikorian, James C. Eliassen, Erin L. Boespflug, Tiffany A. Nash, Marcelle D. Shidler · 2010 · Nutritional Neuroscience
  40. Abnormal Localization of Two Neuronal Calcium Sensor Proteins, Visinin-Like Proteins (VILIPs)-1 and -3, in Neocortical Brain Areas of Alzheimer Disease Patients
    Karl Heinz Braunewell, Peter Franz Riederer, Christina Spilker, Eckart Dieter Gundelfinger, Bernard Bogerts, Hans‐Gert Bernstein · 2001 · Dementia and Geriatric Cognitive Disorders
  41. Insulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer’s disease
    Oliver Stöhr, Katharina Schilbach, Lorna Moll, Moritz M. Hettich, Susanna Freude, Frank Thomas Wunderlich, Marianne B. Ernst, Johanna Zemva, Jens C. Brüning, Wilhelm Krone et al. · 2011 · AGE
  42. Do Delirium and Alzheimer’s Dementia Share Specific Pathogenetic Mechanisms?
    Piet Eikelenboom, Witte J.G. Hoogendijk · 1999 · Dementia and Geriatric Cognitive Disorders
  43. Mitochondrial dysfunction in psychiatric and neurological diseases: Cause(s), consequence(s), and implications of antioxidant therapy
    Deepak Mahadev Kasote, Mahabaleshwar Vishnu Hegde, Surendra S. Katyare · 2013 · BioFactors
  44. Brain-Derived Neurotrophic Factor Plasma Levels: Relationship With Dementia and Diabetes in the Elderly Population
    Angelina Passaro, Edoardo Dalla Nora, Mario Luca Morieri, Cecilia Soavi, Juana María Sanz, Amedeo Zurlo, R. Fellin, Giovanni Zuliani · 2014 · The Journals of Gerontology Series A
  45. Glucose intolerance, cognitive impairment and Alzheimer’s disease
    Matti Vanhanen, Hilkka S. Soininen · 1998 · Current Opinion in Neurology
  46. Relationships Between Diabetes and Cognitive Impairment
    Suzanne M. de la Monte · 2013 · Endocrinology and Metabolism Clinics of North America
  47. State of the science on brain insulin resistance and cognitive decline due to Alzheimer's disease
    Rhea, Elizabeth M., Leclerc, Manon, Yassine, Hussein N., Capuano, Ana W., Tong, Han, Petyuk, Vladislav A., Macauley, Shannon L., Fioramonti, Xavier, Carmichael, Owen, Calon, Frederic et al. · 2023 · Aging and disease
  48. Retinal microvascular abnormalities and cognitive dysfunction: a systematic review
    Jie Ding, Niall Patton, Ian J. Deary, Mark W. J. Strachan, F.G.R. Fowkes, Rebecca J Mitchell, Jackie F. Price · 2008 · British Journal of Ophthalmology
  49. Exenatide exerts cognitive effects by modulating the BDNF-TrkB neurotrophic axis in adult mice
    Manuela Bomba, Alberto Granzotto, Vanessa Castelli, Noemi Massetti, Elena Silvestri, Lorella M.T. Canzoniero, Annamaria Cimini, Stefano Luca Sensi · 2017 · Neurobiology of Aging
  50. Separation methods used in the determination of choline and acetylcholine
    Tung‐Hu Tsai · 2000 · Journal of Chromatography B Biomedical Sciences and Applications
  51. CRISPR–Cas9 screens reveal regulators of ageing in neural stem cells
    Tyson Joel Ruetz, Angela N. Pogson, Chloe M. Kashiwagi, Stephanie D. Gagnon, Bhek Morton, Eric Sun, Jeeyoon Na, Robin W. Yeo, Dena S. Leeman, David W. Morgens et al. · 2024 · Nature
  52. Plasma Amyloid-β Peptide Levels Correlate with Adipocyte Amyloid Precursor Protein Gene Expression in Obese Individuals
    Yong‐ho Lee, Julie Martin, Rhonda L. Maple, William G. Tharp, Richard E. Pratley · 2009 · Neuroendocrinology
  53. Erratum to: Insulin improves memory and reduces chronic neuroinflammation in the hippocampus of young but not aged brains
    Linda Adzovic, Ashley E Lynn, Heather M. D’Angelo, Alexis Mary Crockett, Roxanne M. Kaercher, Sarah E Royer, Sarah C. Hopp, Gary L. Wenk · 2015 · Journal of Neuroinflammation
  54. Human gut microbiota Agathobaculum butyriciproducens improves cognitive impairment in LPS-induced and APP/PS1 mouse models of Alzheimer's disease
    Jun Go, Dong‐Ho Chang, Young‐Kyoung Ryu, Hye‐Yeon Park, In-Bok Lee, Jung‐Ran Noh, Dae Youn Hwang, Byoung‐Chan Kim, Kyoung‐Shim Kim, Chul‐Ho Lee · 2020 · Nutrition Research
  55. Broadening the definition of brain insulin resistance in aging and Alzheimer's disease
    Hilaree N. Frazier, Adam O. Ghoweri, Katie L. Anderson, Ruei‐Lung Lin, Nada M. Porter, Olivier Thibault · 2018 · Experimental Neurology
  56. Lipoic acid restores age‐associated impairment of brain energy metabolism through the modulation of A kt/ JNK signaling and PGC 1α transcriptional pathway
    Tianyi Jiang, Fei Yin, Jia Yao, Roberta Dı́az Brinton, Enrique Cadenas · 2013 · Aging Cell
  57. Diabetes and Alzheimer’s Disease: A Link not as Simple as it Seems
    Isabel H. Salas, Bart De Strooper · 2018 · Neurochemical Research
  58. Minimal Peroxide Exposure of Neuronal Cells Induces Multifaceted Adaptive Responses
    Wayne Chadwick, Yu Zhou, Sung Soo Park, Liyun Wang, Nicholas A. Mitchell, Matthew D. Stone, Kevin G. Becker, Bronwen Martin, Stuart R. Maudsley · 2010 · PLoS ONE
  59. Hyperinsulinemia in rats causes impairment of spatial memory and learning with defects in hippocampal synaptic plasticity by involvement of postsynaptic mechanisms
    Amer Kamal, Geert M. J. Ramakers, Willem Hendrik Gispen, Geert Jan Biessels, Amer Al Ansari · 2013 · Experimental Brain Research
  60. Metabolic triad in brain aging: mitochondria, insulin/IGF-1 signalling and JNK signalling
    Fei Yin, Tianyi Jiang, Enrique Cadenas · 2013 · Biochemical Society Transactions
  61. Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease
    Manuela Bomba, Alberto Granzotto, Vanessa Castelli, MARCO C. ONOFRJ, Rossano Lattanzio, Annamaria Cimini, Stefano Luca Sensi · 2018 · Journal of Alzheimer s Disease
  62. Scuola Normale Superiore
    Gabriele Turi · 2003 · Florence Research (University of Florence)
  63. Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity
    Salinee Jantrapirom, Wutigri Nimlamool, Nipon Chattipakorn, Siriporn Chaisin Chattipakorn, Piya Temviriyanukul, Woorawee Inthachat, Piyarat Govitrapong, Saranyapin Potikanond · 2020 · International Journal of Molecular Sciences
  64. Association between comorbidities and dementia in diabetes mellitus patients: population-based retrospective cohort study
    Shu‐Chen Kuo, Shih‐Wei Lai, Hung‐Chang Hung, Chih‐Hsin Muo, Shih‐Chang Hung, Lingling Liu, Chia-Wei Chang, Yueh‐Juen Hwu, Shieh-Liang Chen, Fung-Chung Sung · 2015 · Journal of Diabetes and its Complications
  65. The Implication of the Brain Insulin Receptor in Late Onset Alzheimer’s Disease Dementia
    Jaume Folch, Miren Ettcheto, Oriol Busquets, Elena Sánchez‐López, Ruben Dario Castro-Torres, Ester Verdaguer, Patrícia Regina Manzine, Saghar Rabiei Poor, Maria Luisa García, Jordi Olloquequi et al. · 2018 · Pharmaceuticals
  66. Gene expression profile in streptozotocin rat model for sporadic Alzheimer?s disease
    Edna Grünblatt, Siegfried Hoyer, Peter Franz Riederer · 2004 · Journal of Neural Transmission
  67. Linking insulin with Alzheimer’s disease: emergence as type III diabetes
    Sara Atito Ali Ahmed, Zahra Mahmood, Saadia Zahid · 2015 · Neurological Sciences
  68. Role of Insulin Signaling in the Interaction Between Alzheimer Disease and Diabetes Mellitus: A Missing Link to Therapeutic Potential
    Naoyuki Sato, Shuko Takeda, Kozue Uchio‐Yamada, Hironori Ueda, Tomomi Fujisawa, Hiromi Rakugi, Ryuichi Morishita · 2011 · Current Aging Science
  69. Macronutrients, aluminium from drinking water and foods, and other metals in cognitive decline and dementia
    Vincenzo Solfrizzi, Anna Maria Colacicco, Alessia D’Introno, Cristiano A. Capurso, Angelo Del Parigi, Sabrina A. Capurso, Francesco Torres, Antonio Capurso, Francesco Panza · 2006 · Journal of Alzheimer s Disease
  70. Brain insulin, insulin‐like growth factor 1 and glucagon‐like peptide 1 signalling in Alzheimer’s disease
    Ferreira, Sergio T. · 2021 · Journal of Neuroendocrinology
  71. Two Birds One Stone: The Neuroprotective Effect of Antidiabetic Agents on Parkinson Disease—Focus on Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors
    Kai-Jung Lin, Tzu‐Jou Wang, Shang‐Der Chen, Kai-Lieh Lin, Chia‐Wei Liou, Min‐Yu Lan, Yao‐Chung Chuang, Jiin‐Haur Chuang, Pei‐Wen Wang, Jong‐Jer Lee et al. · 2021 · Antioxidants
  72. Loss of insulin signaling in astrocytes exacerbates Alzheimer-like phenotypes in a 5xFAD mouse model
    Wenqiang Chen, Qian Huang, Ekaterina Lazdon, Antonio Gomes, Marisa Wong, Emily R. Stephens, Tabitha Grace Royal, Dan Frenkel, Weikang Cai, C. Ronald Kahn · 2023 · Proceedings of the National Academy of Sciences
  73. Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein
    Siegfried Hoyer, Heinrich Lannert · 2007 · Springer eBooks
  74. Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones
    2020 · International Review of Neurobiology
  75. Alzheimer's Disease and Diabetes: New Insights and Unifying Therapies
    Arianna Vignini, Alessia Giulietti, Laura Nanetti, Francesca Raffaelli, Lucia Giusti, Laura Mazzanti, Leandro Provinciali · 2013 · Current Diabetes Reviews
  76. Neuroprotective Mechanisms of PPAR δ : Modulation of Oxidative Stress and Inflammatory Processes
    Caroline I. Schnegg, Mike E. C. Robbins · 2011 · PPAR Research
  77. Adiponectin: The Potential Regulator and Therapeutic Target of Obesity and Alzheimer’s Disease
    J. Y. Kim, Sumit Barua, Yeju Jeong, J. Lee · 2020 · International Journal of Molecular Sciences
  78. Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases.
    Suzanne M. de la Monte · 2012 · PubMed
  79. Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function — role of glucose metabolism and insulin signalling
    Rhein, Virginie, Eckert, Anne · 2007 · Archives of Physiology and Biochemistry
  80. Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine
    Sai Wang Seto, Guoyan Yang, Hosen Kiat, Alan Bensoussan, Yiu Wa Kwan, Dennis Chang · 2015 · International Journal of Endocrinology
  81. N-acetylcysteine protects memory decline induced by streptozotocin in mice
    Michael D. Costa, Jamile Bernardi, Tiago da Luz Fiuza, Lidiane Costa, Ricardo Brandão, Maria Estér Pereira · 2016 · Chemico-Biological Interactions
  82. Dietary Reversal Ameliorates Short- and Long-Term Memory Deficits Induced by High-fat Diet Early in Life
    Catrina Sims‐Robinson, Anna Bakeman, Elizabeth S. Bruno, Samuel Jackson, Rebecca Glasser, Geoffrey G. Murphy, Eva L. Feldman · 2016 · PLoS ONE
  83. Therapeutic targets of brain insulin resistance in sporadic Alzheimer s disease
    Suzanne M. de la Monte · 2012 · Frontiers in Bioscience-Elite
  84. Alzheimer’s Disease and Type 2 Diabetes Mellitus: The Use of MCT Oil and a Ketogenic Diet
    Junpei Takeishi, Yasuko Tatewaki, Taizen Nakase, Yumi Takano, Naoki Tomita, Shuzo Yamamoto, Tatsushi Mutoh, Yasuyuki Taki · 2021 · International Journal of Molecular Sciences
  85. Sporadic Alzheimer's Disease: The Starving Brain
    Mortimer Mamelak · 2012 · Journal of Alzheimer s Disease
  86. Insulin and Insulin-like Growth Factor 1 (IGF-1) Modulate Cytoplasmic Glucose and Glycogen Levels but Not Glucose Transport across the Membrane in Astrocytes
    Marko Muhič, Nina Vardjan, Helena Haque Chowdhury, Robert Zorec, Marko Kreft · 2015 · Journal of Biological Chemistry
  87. Inflammation in the hippocampus affects IGF1 receptor signaling and contributes to neurological sequelae in rheumatoid arthritis
    Karin Andersson, Caroline Wasén, Lina Juzokaite, L. Leifsdottir, Malin C. Erlandsson, Sofia Töyrä Silfverswärd, Anna Stokowska, Marcela Pekna, Milos Pekny, Kjell Olmarker et al. · 2018 · Proceedings of the National Academy of Sciences
  88. The link between iron, metabolic syndrome, and Alzheimer’s disease
    Edna Grünblatt, Jasmin Bartl, Peter Franz Riederer · 2010 · Journal of Neural Transmission
  89. C‐Peptide Prevents Hippocampal Apoptosis in Type 1 Diabetes
    Zhen-guo Li, Weixian Zhang, Anders A. F. Sima · 2002 · Journal of Diabetes Research
  90. Metabolic disorder in Alzheimer’s disease
    Mrinal Kanti Poddar, Soumyabrata Banerjee, Apala Chakraborty, Debasmita Dutta · 2021 · Metabolic Brain Disease
  91. Intra CA1 insulin microinjection improves memory consolidation and retrieval
    Maryam Moosavi, Nasser Naghdi, Samira Choopani · 2007 · Peptides
  92. Targeting Insulin Resistance to Treat Cognitive Dysfunction
    Anit Tyagi, Subbiah Pugazhenthi · 2021 · Molecular Neurobiology
  93. Diabetes Reduces Autophosphorylation of Retinal Insulin Receptor and Increases Protein-Tyrosine Phosphatase-1B Activity
    Raju V. S. Rajala, Brandt J. Wiskur, Masaki Tanito, Michelle C. Callegan, Ammaji Rajala · 2009 · Investigative Ophthalmology & Visual Science
  94. Insulin, Synaptic Function, and Opportunities for Neuroprotection
    Mielke, John G., Wang, Yu-Tian · 2011 · Progress in Molecular Biology and Translational Science
  95. Neuropeptides in Alzheimer’s Disease: An Update
    Carla Petrella, Maria Grazia Di Certo, Christian Barbato, Francesca Gabanella, Massimo Ralli, Antonio Greco, Roberta Possenti, Cinzia Severini · 2019 · Current Alzheimer Research
  96. Nine-month follow-up of the insulin receptor signalling cascade in the brain of streptozotocin rat model of sporadic Alzheimer’s disease
    Jelena Osmanović Barilar, Ana Knezović, Edna Grünblatt, Peter Riederer, M. Salkovic-Petrisic · 2014 · Journal of Neural Transmission
  97. Synaptic plasticity modulation by circulating peptides and metaplasticity: Involvement in Alzheimer’s disease
    Stéphane Peineau, Kevin Rabiant, Olivier Pierrefiche, Brigitte Potier · 2018 · Pharmacological Research
  98. Does Diabetes Protect or Provoke Alzheimer's Disease? Insights Into the Pathobiology and Future Treatment of Alzheimer's Disease
    Hillel T. Grossman · 2003 · CNS Spectrums
  99. Meta-analysis of human prefrontal cortex reveals activation of GFAP and decline of synaptic transmission in the aging brain
    Wasco Wruck, James Adjaye · 2020 · Acta Neuropathologica Communications
  100. A unifying hypothesis of alzheimer's disease
    Kurt Heininger · 2000 · Neurobiology of Aging